In this Essentials episode of the Huberman Lab podcast, Dr. Chris Palmer discusses the connection between nutrition and mental health, focusing on ketogenic diets as a treatment for psychiatric disorders. Palmer shares his personal journey into nutritional psychiatry and presents clinical cases demonstrating how ketogenic diets have helped patients with treatment-resistant depression, schizophrenia, and schizoaffective disorder. He explains the importance of achieving measurable ketosis for therapeutic effects and outlines the specific blood ketone levels needed for different conditions.
The episode explores the broader role of mitochondria in mental health, explaining how these cellular structures regulate neurotransmitters, hormone synthesis, inflammation, and stress responses. Palmer describes how ketogenic diets promote mitochondrial health through mitophagy and biogenesis, and discusses practical considerations for implementing dietary interventions. He emphasizes the distinction between simple dietary improvements for general wellness and the medical supervision required when using ketogenic diets to treat serious psychiatric conditions.

Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
Dr. Chris Palmer's path to nutritional psychiatry began with his own health crisis. During medical training, he struggled with depression, suicidality, and metabolic syndrome despite following standard medical advice. After adopting a low-carb diet inspired by the Atkins approach, Palmer reversed his metabolic conditions and experienced unexpected antidepressant benefits. Working with treatment-resistant patients who had exhausted conventional approaches, Palmer began proposing dietary intervention as an experimental option, and among those who adhered to it, remarkable antidepressant effects emerged.
Palmer's cases demonstrate the potential of ketogenic diets in severe psychiatric disorders. A woman with chronic, treatment-resistant depression shifted from profound depression to hypomania within a month. Another patient, a 33-year-old man with schizoaffective disorder who had failed 17 medication trials, experienced mood improvement within two weeks of starting a ketogenic diet. Over the next six to eight weeks, his psychosis and hallucinations dissipated, he lost 160 pounds, completed a certificate program, and achieved independent living.
Palmer observes that measurable ketosis, confirmed by testing, is vital for these effects. Patients attempting low-carb approaches without achieving ketosis rarely show significant benefits. Optimal blood ketone levels vary by condition: depression typically requires levels above 0.8 millimolar, while severe conditions like schizophrenia and bipolar disorder need levels exceeding 1.5 millimolar.
Mitochondria extend well beyond their traditional role as cellular "powerhouses." Palmer explains that mitochondria function more like a computer's motherboard, directing and allocating cellular resources. They regulate neurotransmitter production and release—including serotonin, [restricted term], glutamate, and acetylcholine—through the Krebs cycle and by enabling vesicle release at synapses. Research shows that removing mitochondria from synapses and supplying ATP alone is insufficient for neurotransmitter release.
Mitochondria also house enzymes for synthesizing steroid hormones like cortisol, estrogen, [restricted term], and progesterone. Mitochondrial dysfunction can lead to hormonal imbalances contributing to psychiatric symptoms. Additionally, mitochondria regulate inflammation through reactive oxygen species, which serve as signals to turn inflammation off. They coordinate all facets of the stress response, including cortisol, adrenaline, inflammation, and gene expression changes.
The ketogenic diet was developed in 1921 by Dr. Russell Wilder at the Mayo Clinic specifically to treat epilepsy, building on observations dating back to Hippocrates that fasting could stop seizures. Early trials showed about half of patients became seizure-free, with an overall efficacy rate of roughly 85%. When the diet was revived at Johns Hopkins in the 1970s for treatment-resistant epilepsy, approximately one-third of patients became seizure-free and another third experienced significant clinical benefit.
Decades of epilepsy research reveal the ketogenic diet affects neurotransmitter levels, regulates calcium channels, alters gene expression, reduces brain inflammation, and changes the gut microbiome. These findings lend legitimacy to psychiatric applications by demonstrating that nutrition can profoundly affect brain conditions previously deemed out of reach for dietary intervention.
Palmer explains that ketogenic diets stimulate mitophagy—the selective removal of old and defective mitochondria—and mitochondrial biogenesis, the creation of new mitochondria. Fasting and ketogenic diets preferentially eliminate compromised mitochondria while preserving healthy ones. After weeks on a ketogenic diet, cells contain more and healthier mitochondria, enhancing cellular energy production and metabolic regulation.
This process is triggered when the body senses nutrient scarcity and enters a state where it recycles problematic cellular components in a carefully regulated way. These enhancements in mitochondrial health support neurotransmitter production, hormone synthesis, and coordination of inflammatory and stress responses, providing a mechanism linking dietary intervention to improvements in mood, psychotic symptoms, and emotional regulation.
Palmer distinguishes between root causes of psychiatric symptoms and effective treatments, noting that dietary interventions can induce beneficial metabolic changes across the spectrum. For individuals not under psychiatric care, eliminating junk food and reducing sweets may provide substantial benefits. He shares a case of a vegetarian with chronic anxiety who alleviated symptoms within three weeks by cutting high-carb foods.
However, for chronic psychiatric disorders like bipolar disorder, schizophrenia, or treatment-resistant depression, a full ketogenic diet targeting specific blood ketone levels is necessary. Palmer emphasizes that professional supervision is essential when implementing dietary interventions for serious mental illnesses. As nutritional therapy can enhance brain function, psychiatric medications may need adjustment, and tapering medication requires careful medical management. He warns against self-directed approaches, stressing that treating psychiatric illness with diet requires rigorous medical oversight to ensure safety and effectiveness.
1-Page Summary
During his medical training, Dr. Chris Palmer finds himself struggling with depression, suicidality, and eventually receives a diagnosis of metabolic syndrome – including high blood pressure, poor lipid levels, and pre-diabetes – despite following standard medical advice. Traditional dietary recommendations fail him, and his condition worsens. Turning to a low-carb diet inspired by the Atkins approach, Palmer adopts strict meal planning and adherence. With time, he reverses his metabolic metabolic syndrome, seeing improvements in blood pressure, cholesterol, and pre-diabetes.
Observing unexpectedly strong antidepressant benefits from the dietary change, Palmer begins to consider its potential for patients in his clinical practice. Working in a tertiary care hospital, Palmer primarily sees individuals with treatment-resistant mental disorders who have tried six or more psychiatrists, dozens of medications, extensive therapy, electroconvulsive therapy, and still have significant symptoms. With conventional approaches exhausted for many patients, Palmer proposes the dietary intervention as an experimental option. Some patients are interested and able to adhere to it, and among those, a remarkable antidepressant effect emerges.
Among Palmer’s first cases, a woman with chronic, treatment-resistant depression and suicidality for more than five years tries the ketogenic diet. Within a month, she shifts from profound depression to hypomania, marking a dramatic and rapid reversal reminiscent of pharmaceutical effects, but even more impactful.
Another case involves a 33-year-old man with schizoaffective disorder, suffering daily auditory hallucinations, paranoid delusions, severe social impairment, and weighing 340 pounds. After 17 failed medication trials and years of disability, he adopts a ketogenic diet seeking weight loss and symptom improvement. Within two weeks, his mood improves and he becomes more sociable. Over the next six to eight weeks, his psychosis and hallucinations begin to dissipate to the point he recognizes his previous beliefs were delusional and feels his schizophrenia is resolving. He ultimately loses 160 pounds, maintains his weight, completes a certificate program, ventures out in public without fear, performs improv, and achieves independent living in his own apartment.
These cases, and others in Palmer’s practice, illustrate that dietary intervention can yield significant benefits for psychiatric patients who have not responded to years of medication and therapy. The effects are seen across severe disorders and in patients who have faced decades of disability.
Palmer observes that patients who attempt low-carb approaches like the Atkins diet but do not achieve measurable ketosis, as ...
Nutrition's Role in Mental Health: Case Studies on Ketogenic Diets Improving Treatment-Resistant Psychiatric Disorders
Mitochondria play multifaceted roles in cellular health, extending well beyond their traditional view as the cell’s “powerhouse.” Research reveals their involvement in regulating neurotransmitters, hormones, inflammation, and stress responses, directly linking mitochondrial function to metabolic and mental health.
Chris Palmer explains that while many consider mitochondria merely as providers of energy—akin to the power cord for a computer—their primary function resembles a computer’s motherboard. Mitochondria direct and allocate resources throughout the cell, orchestrating essential metabolic processes and responding to changes in cellular needs. Their actions underlie how dietary and metabolic interventions can influence psychiatric disorders, as mitochondrial activity reveals how these interventions affect brain function and mental health.
Mitochondria are crucial for both the synthesis and release of neurotransmitters. Through the Krebs cycle, mitochondria supply building blocks necessary for making neurotransmitters. They provide intermediates for neurotransmitter synthesis and supply the energy required for their production through ATP generation. Notably, mitochondria do more than just produce energy; they also enable the actual release of neurotransmitters at synapses.
Research shows that mitochondria move along synaptic membranes to release neurotransmitter vesicles. Experiments demonstrate that removing mitochondria from the synapse and supplying ATP alone is insufficient for neurotransmitter release—indicating that mitochondria perform other essential, not yet fully understood roles in this process.
The primary neurotransmitters influenced by mitochondrial function include serotonin, [restricted term], glutamate, and acetylcholine. These molecules regulate mood, motivation, cognition, and the stress response. Any excess or deficiency in these neurotransmitters, caused by mitochondrial dysfunction, can result in profound negative effects on the nervous system and contribute to psychiatric conditions.
Mitochondria contain enzymes needed for synthesizing major steroid hormones such as cortisol, estrogen, [restricted term], and progesterone. If mitochondria are dysfunctional or diminished in number, the production of these hormones becomes dysregulated. This metabolic dysfunction can lead to hormonal imbalances that contribute to mood disturbances and psychiatric symptoms, directly tying mitochondrial health to both metabolic and mental disorders.
Mitochondria play a pivotal role in regulating inflammation. They initiate and resolve inflammatory responses via signaling molecules, especially reactive oxygen spec ...
Mitochondrial Role in Metabolic and Mental Health: Impact on Neurotransmitters, Hormones, Inflammation, Cellular Stress
The ketogenic diet was developed in 1921 by Dr. Russell Wilder at the Mayo Clinic exclusively to treat epilepsy, not as a weight loss or general dietary plan. This intervention emerged from longstanding observations, dating back to Hippocrates, that fasting could stop seizures. In 1921, physicians trialed intermittent fasting in children with epilepsy and found it reduced seizures. However, fasting could not be maintained long-term without risking starvation, and seizures would return when normal eating resumed. Dr. Wilder designed the ketogenic diet to mimic the metabolic effects of fasting through nutrition, allowing long-term seizure control without the dangers of starvation. These early results demonstrated the power of nutrition as a tool to treat neurological disorders, proving that specific dietary manipulations could have a lasting impact on brain health and function.
Early clinical trials found that the ketogenic diet achieved extraordinary outcomes for epilepsy patients: about half of patients following the diet became seizure-free, and another 35% experienced more than a 50% reduction in seizure frequency. This led to an overall efficacy rate of roughly 85%. By the 1950s, pharmaceutical anticonvulsants for epilepsy became widely available and benefited many, yet approximately 30% of people with epilepsy remain unresponsive to these medications even after trying multiple drugs or undergoing brain surgery.
In the 1970s, the ketogenic diet was revived at Johns Hopkins specifically for cases of treatment-resistant epilepsy. The results validated earlier findings: about one-third of patients became seizure-free, another third had a significant clinical benefit (at least a 50% seizure reduction), while the remaining third saw no improvement. This efficacy in intractable epilepsy reinforced the diet’s value in neurology and sparked additional research into its therapeutic mechanisms and broader neurological relevance.
Ketogenic Diet: Nutrition's Power In Treating Serious Neurological and Psychiatric Conditions
Chris Palmer explains that ketogenic diets stimulate important cellular processes—mitophagy and mitochondrial biogenesis—directly impacting brain and mental health by renewing the mitochondria in our bodies and brains.
Mitophagy is a selective process through which the body targets only old and defective mitochondria for destruction, rather than destroying healthy tissue. Defective mitochondria are identified, transported to lysosomes, and then degraded. The resulting breakdown products are recycled, either used directly for energy or used to build new cellular components.
Fasting and ketogenic diets initiate mitophagy in a way that preferentially eliminates compromised mitochondria. This selective removal process ensures that the healthiest organelles remain, improving cellular efficiency and reducing the risk of cellular malfunction caused by damaged mitochondria.
In addition to mitophagy, ketogenic diets also stimulate mitochondrial biogenesis—the formation of new mitochondria. After weeks or months on a ketogenic diet, many cells in the body and brain contain more mitochondria, and the mitochondria themselves are healthier.
An increased number of higher-quality mitochondria enhances the cell’s capacity for energy production and improves metabolic regulation. This leads to more efficient cellular function throughout the body, including the brain.
Autophagy, including mitophagy, is a process always occurring at a low level. However, it can be powerfully stimulated through fasting, caloric restriction, and fasting-mimicking diets. Palmer explains that when the body senses a lack of food, it enters a state in which it recycles old or dead cellular components in a carefully regulated way, thus improving longevity and cellular function.
Mitophagy and Mitochondrial Biogenesis Triggered by Ketogenic Diets For Better Brain and Mental Health
Chris Palmer emphasizes the need to distinguish between the root causes of psychiatric symptoms and the effective treatments available. He highlights that dietary interventions such as calorie restriction, carbohydrate restriction, and ketogenic diets can induce beneficial metabolic changes in the brain, offering significant potential in the care of mental health conditions.
Palmer notes that for some individuals—particularly those not under psychiatric care or on medication—substantial mental health benefits can be achieved by simply eliminating junk food and reducing sweets, which lowers glucose and [restricted term] levels. General burnout or mood issues in otherwise healthy people may improve significantly through moderate carbohydrate restriction, without the need for full ketosis.
He shares an illustrative case of a vegetarian experiencing chronic anxiety who managed to alleviate symptoms within three weeks by cutting out high-carb foods, foregoing medication altogether. This demonstrates that, for some, dietary improvement alone can have a profound effect on mental health.
However, Palmer clarifies that for those experiencing chronic psychiatric disorders such as bipolar disorder, schizophrenia, or treatment-resistant depression, mild interventions may not suffice. In these cases, a full ketogenic diet designed to reach particular blood ketone levels is required to produce meaningful changes in brain function and symptom management.
Palmer stresses the importance of targeting specific blood ketone levels, rather than following generic weight loss or wellness diets, for psychiatric applications. For depression, the aim is to achieve blood ketone levels above 0.8 millimolar for noticeable therapeutic benefit. In more severe psychiatric disorders like schizophrenia and bipolar disorder, he targets levels greater than 1.5 millimolar to achieve optimal symptom reduction. This tailored approach helps ensure the diet’s metabolic effects are sufficient for addressing serious psychiatric conditions.
Palmer repeatedly underscores the necessity of professional supervision when implementing dietary interventions for those w ...
Dietary Interventions for Mental Health: Ketone Targets, Condition Recommendations, and Medical Supervision
Download the Shortform Chrome extension for your browser
